This Startup Is Billionaire Reid Hoffman's Next Big Bet Hoffman sold LinkedIn, which he co-founded, to Microsoft for $26.2 billion in 2016.

By Sherin Shibu Edited by Melissa Malamut

Key Takeaways

  • LinkedIn co-founder Reid Hoffman is teaming up with author and professor Dr. Siddhartha Mukherjee to launch Manas AI, a new biotechnology startup.
  • Manas aims to bring AI to researchers for quicker drug development.
  • The startup has raised $24.6 million in seed funding so far.

LinkedIn co-founder Reid Hoffman became a billionaire when Microsoft bought LinkedIn in 2016 for $26.2 billion in cash, and he has also made his fortune on high-return investments in more than 80 tech startups, including Airbnb, Groupon, and Flickr. He famously made $111 million from his initial $37,500 investment in Facebook.

Now Hoffman is turning his attention to AI in healthcare with a new startup he introduced last week with co-founder Dr. Siddhartha Mukherjee: Manas AI. And this time Hoffman has deeper hopes than just a high return on investment — he wants to help cure cancer.

Manas is bringing AI to some of the world's top drug development scientists to deepen their expertise and speed up the rate at which new drugs are discovered. The startup aims to unite researchers with advanced AI systems to more quickly figure out how potentially life-saving drugs could interact with the human body.

Related: LinkedIn's Reid Hoffman: To Scale, Do Things That Don't Scale

Manas is initially turning its attention to aggressive cancers like breast cancer, prostate cancer, and lymphoma. Its long-term vision is to fundamentally change how the industry discovers and develops new medicines.

"Most people have had friends, family members, etc., who've died from cancer or had serious cancer problems," Hoffman told CNBC on Monday. "If we can make a huge difference on this, and this is the kind of thing that AI can make a huge difference in, it's the kind of reason why AI can be great for humanity."

Reid Hoffman The Midway SF on December 05, 2023, in San Francisco, California. Photo by Kimberly White/Getty Images for WIRED

The startup has raised $24.6 million in seed funding so far, with Hoffman leading the funding round with venture capital firm General Catalyst. It will operate its AI systems in data centers owned by Microsoft.

Related: Reid Hoffman: To Successfully Grow A Business, You Must 'Expect Chaos'

Mukherjee is a Columbia University professor and author of "The Emperor of All Maladies," a book about cancer. In 2016, he helped found Vor BioPharma, a cell engineering company, and in 2021 he founded Myeloid Therapeutics, a cancer therapy startup.

Manas currently has four employees including Mukherjee and Hoffman, with Hoffman saying he serves as the company's "AI guy" and Mukherjee as the "bio guy." Manas' goal is to unite the two fields.

"It isn't just the best of science and it isn't just the best of AI, because either of those two [is] insufficient," Hoffman told CNBC. "You need to put those two together."

The AI healthcare sector saw substantial investments in 2024. According to PitchBook, investors poured $10.5 billion into 511 healthcare AI deals in 2024. Cancer screening AI startup Freenome raised the most money out of the group with a $254 million Series F in February 2024.

Sherin Shibu

Entrepreneur Staff

News Reporter

Sherin Shibu is a business news reporter at Entrepreneur.com. She previously worked for PCMag, Business Insider, The Messenger, and ZDNET as a reporter and copyeditor. Her areas of coverage encompass tech, business, strategy, finance, and even space. She is a Columbia University graduate.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Business Process

I Use the 6-Week Sprint Method For Better Product Development — and More. Here's Why You Need It, Too.

Discover how the six-week sprint model reshapes product development, eliminating backlogs, encouraging rapid iteration and fostering adaptability for startups to thrive in an unpredictable market.

Fundraising

22 Cap Table Red Flags That Can Derail Your Fundraising (and How to Fix Them)

A poorly structured cap table is a silent killer of fundraising efforts. Here are some common red flags that can cost you valuable investments.

Business Plans

Top 10 Business Plan Mistakes

When it comes to creating a business plan that attracts investors, these tips will help you get it right the first time.

Science & Technology

10 Apps and Tools to Make Your Small Business Better and More Efficient

When you don't have the resources to build custom solutions, you can rely on these affordable (or free) fixes.

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.